
Sign up to save your podcasts
Or


Your competitors are pitching "AI-native" platforms, and you're wondering whether your piecemeal approach to RCM automation can possibly keep up. Should you rip everything out and rebuild around one giant AI system?
In part two of this series, Sean McSweeney challenges the idea that AI-native is automatically better. He explains why a modular approach to RCM automation can be lower risk, more flexible, and easier to improve as technology changes.
What You'll Learn:
Start automating the pieces where AI works today, and expand your RCM automation iteratively instead of betting everything on a single platform.
Private equity keeps funding well-capitalized startups that promise a fully automated future, and you are left wondering whether your medical billing company can survive against an AI native RCM competitor with nine figures in the bank.
Sean McSweeney challenges the fear and hype around AI native RCM platforms. He separates the investor pitch from operational reality and draws on his own early mistakes entering medical billing to explain why a company built from scratch may not be the unstoppable force it appears to be.
What You'll Learn:
Competition from AI native RCM companies is real, but this episode makes the case that you do not need to panic about being wiped out overnight.
From the publisher's feed

200 Listeners

10,727 Listeners